FdaApplication
NDA 209482
Identifiers
- fda_app_no: NDA209482
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND |
| application_type | NDA |
| approval_date | 2017-09-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRELEGY ELLIPTA | FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH | POWDER;INHALATION |
| TRELEGY ELLIPTA | FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | 0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH | POWDER;INHALATION |
2 products